Search Results 781-790 of 16195 for chemoprevention
This phase II trial studies how well vemurafenib and cobimetinib work in treating patients with BRAF V600E mutation positive craniopharyngioma.
Monoclonal antibodies, such as nivolumab, may stimulate the immune system in different ways and kill tumor cells remaining after surgery and standard of care ...
The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based ...
Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 ...
The purpose of this study is to evaluate sexual well-being in minority women who have been diagnosed with cancer, and their partners. Participation eligibility.
Vasmatzis, George Ph.D. Vasmatzis.George@mayo.edu; Assistant Professor of Laboratory Medicine and Pathology; Associate Professor of Molecular Medicine ...
About this study. Collection of blood to track serial circulating tumor cells (CTCs) in subjects with metastatic breast cancer (MBC).
In collaboration with Google Health, researchers at Mayo Clinic have trained a deep learning model in autosegmentation for head and neck cancer, ...
Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping ...
PURPOSE: This randomized phase III trial studies how well an accelerated course of higher per daily radiation therapy with concomitant boost works compared to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.